Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 7 | $570,939 |
| Sells | 44 | $37,879,495 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 28 Mar 2025 17:36 | NAMS | NewAmsterdam Pharma Co N.V. | TOPPER JAMES N | Director | 26 Mar 2025 | Purchase | 1,135 | 22.4851 | 25,521 | I |
| 28 Mar 2025 17:18 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 26 Mar 2025 | Sale | 16,539 | 0 | 0 | D |
| 28 Mar 2025 17:15 | NAMS | NewAmsterdam Pharma Co N.V. | DAVIDSON MICHAEL H. | Chief Executive Officer | 26 Mar 2025 | Sale | 12,258 | 0 | 0 | D |
| 19 Mar 2025 17:29 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 17 Mar 2025 | Sale | 100,000 | 0 | 0 | D |
| 06 Mar 2025 17:32 | NAMS | NewAmsterdam Pharma Co N.V. | TOPPER JAMES N | Director | 04 Mar 2025 | Purchase | 4,005 | 21.0245 | 84,203 | I |
| 05 Mar 2025 18:10 | NAMS | NewAmsterdam Pharma Co N.V. | KOOIJ LOUISE FREDERIKA | Chief Accounting Officer | 04 Mar 2025 | Sale | 150,000 | 20.37 | 3,055,500 | D |
| 20 Feb 2025 17:24 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 18 Feb 2025 | Sale | 90,782 | 0 | 0 | D |
| 20 Feb 2025 17:24 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 19 Feb 2025 | Sale | 9,218 | 0 | 0 | D |
| 31 Jan 2025 17:00 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 29 Jan 2025 | Sale | 56,863 | 0 | 0 | D |
| 31 Jan 2025 17:00 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 30 Jan 2025 | Sale | 4,664 | 0 | 0 | D |
| 31 Jan 2025 17:00 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 30 Jan 2025 | Sale | 8,914 | 0 | 0 | D |
| 29 Jan 2025 17:25 | NAMS | NewAmsterdam Pharma Co N.V. | SOMAIYA MAYUR IAN | Chief Financial Officer | 27 Jan 2025 | Sale | 33,679 | 0 | 0 | D |
| 29 Jan 2025 17:25 | NAMS | NewAmsterdam Pharma Co N.V. | SOMAIYA MAYUR IAN | Chief Financial Officer | 27 Jan 2025 | Sale | 13,304 | 0 | 0 | D |
| 29 Jan 2025 17:25 | NAMS | NewAmsterdam Pharma Co N.V. | SOMAIYA MAYUR IAN | Chief Financial Officer | 28 Jan 2025 | Sale | 11,495 | 0 | 0 | D |
| 29 Jan 2025 17:25 | NAMS | NewAmsterdam Pharma Co N.V. | SOMAIYA MAYUR IAN | Chief Financial Officer | 28 Jan 2025 | Sale | 3,405 | 0 | 0 | D |
| 29 Jan 2025 17:16 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 27 Jan 2025 | Sale | 80,359 | 0 | 0 | D |
| 29 Jan 2025 17:16 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 27 Jan 2025 | Sale | 23,815 | 0 | 0 | D |
| 29 Jan 2025 17:16 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 28 Jan 2025 | Sale | 20,237 | 0 | 0 | D |
| 29 Jan 2025 17:16 | NAMS | NewAmsterdam Pharma Co N.V. | KLING DOUGLAS F | Chief Operating Officer | 28 Jan 2025 | Sale | 5,148 | 0 | 0 | D |
| 02 Jan 2025 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 30 Dec 2024 | Sale | 29,846 | 25.5369 | 762,174 | I |
| 30 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 26 Dec 2024 | Sale | 33,438 | 26.0072 | 869,629 | I |
| 30 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 27 Dec 2024 | Sale | 41,472 | 25.9522 | 1,076,290 | I |
| 26 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 20 Dec 2024 | Sale | 44,143 | 25.5305 | 1,126,993 | I |
| 26 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 20 Dec 2024 | Sale | 5,629 | 26.1274 | 147,071 | I |
| 26 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 23 Dec 2024 | Sale | 25,132 | 25.4904 | 640,625 | I |
| 26 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 24 Dec 2024 | Sale | 16,164 | 25.6639 | 414,831 | I |
| 20 Dec 2024 16:25 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 18 Dec 2024 | Sale | 54,518 | 25.7172 | 1,402,050 | I |
| 20 Dec 2024 16:25 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 18 Dec 2024 | Sale | 46,210 | 26.5496 | 1,226,857 | I |
| 20 Dec 2024 16:25 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 19 Dec 2024 | Sale | 56,506 | 25.4452 | 1,437,806 | I |
| 18 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 16 Dec 2024 | Sale | 1,096 | 25 | 27,400 | I |
| 18 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 17 Dec 2024 | Sale | 66,648 | 25.6019 | 1,706,315 | I |
| 18 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 17 Dec 2024 | Sale | 47,736 | 26.4463 | 1,262,441 | I |
| 16 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 12 Dec 2024 | Sale | 140,048 | 25.25 | 3,536,212 | I |
| 16 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 12 Dec 2024 | Sale | 25,963 | 26.1763 | 679,615 | I |
| 16 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 13 Dec 2024 | Sale | 25,751 | 25.0106 | 644,048 | I |
| 12 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 10 Dec 2024 | Sale | 259,739 | 25.2184 | 6,550,202 | I |
| 12 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 10 Dec 2024 | Sale | 48,511 | 26.1509 | 1,268,606 | I |
| 12 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 11 Dec 2024 | Sale | 130,561 | 25.2637 | 3,298,454 | I |
| 12 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 11 Dec 2024 | Sale | 18,583 | 26.405 | 490,684 | I |
| 12 Dec 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 11 Dec 2024 | Sale | 4,894 | 27.109 | 132,671 | I |
| 19 Nov 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 15 Nov 2024 | Sale | 8,530 | 25.0218 | 213,436 | I |
| 19 Nov 2024 16:15 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 18 Nov 2024 | Sale | 33,273 | 25.0786 | 834,440 | I |
| 15 Nov 2024 16:36 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 13 Nov 2024 | Sale | 1,066 | 25.0043 | 26,655 | I |
| 15 Nov 2024 16:36 | NAMS | NewAmsterdam Pharma Co N.V. | FORGROWTH NAP B.V. | 10% | 14 Nov 2024 | Sale | 9,832 | 25.0057 | 245,856 | I |
| 01 Oct 2024 17:23 | NAMS | NewAmsterdam Pharma Co N.V. | KOOIJ LOUISE FREDERIKA | Chief Accounting Officer | 01 Oct 2024 | Sale | 45,000 | 15.72 | 707,400 | D |
| 30 Sep 2024 17:22 | NAMS | NewAmsterdam Pharma Co N.V. | AUDET JULIETTE BERANGERE | Chief Business Officer | 26 Sep 2024 | Purchase | 1,104 | 15.7 | 17,333 | D |
| 22 Aug 2024 16:30 | NAMS | NewAmsterdam Pharma Co N.V. | DAVIDSON MICHAEL H. | Chief Executive Officer | 20 Aug 2024 | Purchase | 5,000 | 16.27 | 81,350 | D |
| 24 Jun 2024 08:30 | NAMS | NewAmsterdam Pharma Co N.V. | DAVIDSON MICHAEL H. | Chief Executive Officer | 20 Jun 2024 | Purchase | 5,000 | 17.2617 | 86,308 | D |
| 28 Mar 2024 16:30 | NAMS | NewAmsterdam Pharma Co N.V. | TOPPER JAMES N | Director | 26 Mar 2024 | Purchase | 8,429 | 21.5 | 181,224 | I |
| 27 Mar 2024 16:30 | NAMS | NewAmsterdam Pharma Co N.V. | KASTELEIN JOHANNES JACOB PIETER | Chief Scientific Officer | 26 Mar 2024 | Sale | 190,476 | 21.5 | 4,095,234 | I |
| 21 Feb 2024 17:00 | NAMS | NewAmsterdam Pharma Co N.V. | LANGE LOUIS G | Director | 13 Feb 2024 | Purchase | 5,000 | 19 | 95,000 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)